20% Savings: IBC’s BioProcess International Conference & Exhibition China

20% Savings: IBC’s BioProcess International Conference & Exhibition China
August 19-20, Grand Hyatt Hotel, Shanghai, China

This is China’s foremost event on BioProcessing and Biomanufacturing, providing you with the most timely information, tools, strategies and techniques to ensure optimal development, from upstream to scale-up to commercialization. BPI China provides the most comprehensive coverage of China’s evolving biologics market. From harnessing novel cell line technologies to enhancing analytical capabilities, benchmarking your biosimilar program or meeting complex drug product and manufacturing challenges, BPI China has complete coverage on all of your bioprocessing needs.

BPI China offers a variety of featured presentations as well as keynote presentations from International and China-based companies.

Keynote Presentations:

• Facility Design in China
  Wu Jun, Executive Development Teacher, China’s State Food and Drug
  Administration (SFDA)

• EU-GMP Facility Compliance
  Magnus Jahnsson, MS, Director of Regulatory Affairs, Quality and Project Management, Pharmadule Morimatsu, Sweden

• Biosimilar mAbs in China
  DQ Wang, Ph.D., Director of External Drug Products, Global Biological Development, Bayer HealthCare LLC

• Regulatory and Scientific Considerations for Development
  Duu-Gong Wu, Ph.D., Director of Regulatory Consulting/Senior Consultant, Global Regulatory Consultant, PPD, USA and former Supervisory Chemist, U.S. FDA

Featured Presentations:

• CHO-L1 Cell Line Development
  Wenzhi Tian, M.D., Chief Executive Officer, Huabo Biopharm CO., Ltd., China

• Antibody Drug Development
  Yan Luan, Ph.D., Senior Scientist, Research and Development, DingFu bio Co., China

New registrations save 20% with priority code BPC14BEQP. Visit http://bit.ly/1pfRibQ to download a copy of our English or Chinese event brochure.